Literature DB >> 11551481

The ability of certain antimutagenic agents to prevent development of antibiotic resistance.

S P Pillai1, C A Pillai, D M Shankel, L A Mitscher.   

Abstract

Resistance to multiple antimicrobial agents has now become a prominent fact of contemporary life. It is believed that poor patient compliance, e.g. interrupted or premature cessation of therapy; and misuse or abuse of antibiotics, e.g. wrong antibiotic or insufficient dose, play important roles in resistance development. We present evidence that, this form of resistance often stems from spontaneous mutations accompanied by the positive selecting pressure of the doses of antibiotics being between the MIC and MBC levels. A number of antimutagenic agents, e.g. green tea catechins, and other antioxidants, etc. are able to suppress the emergence of resistance. In many cases, these agents are capable of exerting these effects at doses which by themselves produce no visible effect on growth. In a number of cases antimutagenic substances capable of preventing resistance emergence are present in normal food stuffs. These effects are exerted against resistance to tetracyclines, fluoroquinolones, macrolides, beta-lactams, aminoglycosides and the like. The implications of these laboratory findings for practical chemotherapy are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551481     DOI: 10.1016/s1383-5718(01)00219-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  The antimutagenicity of 2-substituted selenazolidine-4-(R)-carboxylic acids.

Authors:  Wael M El-Sayed; Warda A Hussin; Michael R Franklin
Journal:  Mutat Res       Date:  2006-12-12       Impact factor: 2.433

2.  Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.

Authors:  Keith Miller; Alexander J O'Neill; Mark H Wilcox; Eileen Ingham; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

3.  Novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogs as antibacterial agents: a structural activity relationship.

Authors:  Warda A Hussin; Mohamed A Ismail; Wael M El-Sayed
Journal:  Drug Des Devel Ther       Date:  2013-03-22       Impact factor: 4.162

4.  Comparative study of the antimutagenic properties of vitamins C and E against mutation induced by norfloxacin.

Authors:  Myriam Arriaga Alba; Roberto Rivera Sánchez; Nancy Jannet Ruíz Pérez; Jaime Sánchez Navarrete; Rocío Flores Paz; Araceli Montoya-Estrada; Juan José Hicks Gómez
Journal:  BMC Pharmacol       Date:  2008-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.